Literature DB >> 3978635

Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins.

K J Adams, J Carmichael, C R Wolf.   

Abstract

The mouse bone marrow has been used as a model for the investigation of the response of cells to cytotoxins and carcinogens. The effects of cyclophosphamide, 1-beta-D-arabinofuranosylcytosine, and X-irradiation on the levels of glutathione and glutathione transferases have been studied. A high dose of cyclophosphamide (500 mg/kg) caused a significant depletion of glutathione levels in marrow, liver, and blood. A lower dose, 75 mg/kg, caused a similar depletion but only in marrow and liver. In this case, 5 to 7 days following treatment, the glutathione content of surviving cells was 1.8- to 3-fold higher than in controls. Glutathione transferase activity was also increased at this time (2- to 3-fold). 1-beta-D-Arabinofuranosylcytosine and X-irradiation also caused a depletion of marrow glutathione and glutathione transferase levels followed increased cellular levels (approximately 2-fold) 3 to 4 days later. Animals given cyclophosphamide (75 mg/kg) survived an otherwise lethal dose of this compound administered 5 to 7 days later. The time course of this effect closely paralleled the higher glutathione and glutathione transferase levels, suggesting a correlation between these effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978635

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.

Authors:  S R Tipnis; D G Blake; A G Shepherd; L I McLellan
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil.

Authors:  S M Black; J D Beggs; J D Hayes; A Bartoszek; M Muramatsu; M Sakai; C R Wolf
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi.

Authors:  C J Henderson; C R Wolf; N Kitteringham; H Powell; D Otto; B K Park
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Time-Dependent Measurement of Nrf2-Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation Injury.

Authors:  Kate Liu; Elizabeth Singer; Whitaker Cohn; Ewa D Micewicz; William H McBride; Julian P Whitelegge; Joseph A Loo
Journal:  Proteomics Clin Appl       Date:  2019-09-04       Impact factor: 3.494

6.  Influence of scheduling on two-drug combinations of alkylating agents in vivo.

Authors:  B A Teicher; S A Holden; S M Jones; J P Eder; T S Herman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Glutathione localization by a novel o-phthalaldehyde histofluorescence method.

Authors:  G I Murray; M D Burke; S W Ewen
Journal:  Histochem J       Date:  1986-08

8.  Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards.

Authors:  A D Lewis; I D Hickson; C N Robson; A L Harris; J D Hayes; S A Griffiths; M M Manson; A E Hall; J E Moss; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine.

Authors:  L Hogarth; M English; L Price; R Wyllie; A D Pearson; A G Hall
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

10.  Glutathione S-transferase isoenzymes in human tumours and tumour derived cell lines.

Authors:  A D Lewis; L M Forrester; J D Hayes; C J Wareing; J Carmichael; A L Harris; M Mooghen; C R Wolf
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.